-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on Edwards Lifesciences, Raises Price Target to $84

Benzinga·11/03/2025 13:28:06
Listen to the news
Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $81 to $84.